Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS

Pérez-Robles, Raquel; Salmerón-García, Antonio; Clemente-Bautista, Susana; Jiménez-Lozano, Inés; Cabañas-Poy, María Josep; Cabeza, José; Navas, Natalia

doi:10.1039/d2ay01254e

Anal. Methods

2022

DOI: 10.1039/d2ay01254e

|View full text |Cite

Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS

Raquel Pérez-Robles

Antonio Salmerón-García

Susana Clemente-Bautista

et al.

Abstract: Teduglutide (Revestive®, 10mg/mL) is a recombinant human glucagon-like peptide 2 analogue indicated for the treatment of the short bowel syndrome, a serious and highly disabling condition which results from either...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS

Abstract: Teduglutide (Revestive®, 10mg/mL) is a recombinant human glucagon-like peptide 2 analogue indicated for the treatment of the short bowel syndrome, a serious and highly disabling condition which results from either...

Cited by 1 publication

References 24 publications

Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing

Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing

Contact Info

Product

Resources

About